Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hauke Walter

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Medical Research|October 16, 2007
Determination of HIV-1 coreceptor tropism in clinical practiseAgnes Foeglein, Hauke Walter
Intervirology|January 31, 2012
Targets for inhibition of HIV replication: entry, enzyme action, release and maturationSaleta Sierra-Aragón, Hauke Walter
HIV Clinical Trials|May 29, 2002
Technologies for measuring HIV-1 drug resistanceBarbara Schmidt, Klaus Korn, Hauke Walter
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Association between HIV-1 coreceptor usage and resistance to broadly neutralizing antibodiesNico Pfeifer, Hauke Walter, Thomas Lengauer
Journal of Clinical Microbiology|August 9, 2003
Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test resultsKlaus Korn, Heide Reil, Hauke Walter, et al.
AIDS Reviews|November 6, 2002
Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapyBarbara Schmidt, Hauke Walter, Nina Zeitler, et al.
Journal of the International AIDS Society|November 15, 2014
Appearance of NS3 Q80K mutation in HCV genotype 1a mono- or HIV/HCV co-infected patients in a Berlin laboratoryRobert Ehret, Stefan Neifer, Hauke Walter, et al.
Journal of the International AIDS Society|November 15, 2014
Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequencesAlejandro Pironti, Nico Pfeifer, Rolf Kaiser, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Prediction of abacavir resistance from genotypic data: impact of zidovudine and lamivudine resistance in vitro and in vivoHauke Walter, Barbara Schmidt, Marianne Werwein, et al.
Antiviral Research|March 23, 2010
The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitroDaniel Drogan, Pia Rauch, Daniel Hoffmann, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Medical Research|October 16, 2007
Determination of HIV-1 coreceptor tropism in clinical practiseAgnes Foeglein, Hauke Walter
Intervirology|January 31, 2012
Targets for inhibition of HIV replication: entry, enzyme action, release and maturationSaleta Sierra-Aragón, Hauke Walter
HIV Clinical Trials|May 29, 2002
Technologies for measuring HIV-1 drug resistanceBarbara Schmidt, Klaus Korn, Hauke Walter
Journal of Acquired Immune Deficiency Syndromes (1999)|July 30, 2014
Association between HIV-1 coreceptor usage and resistance to broadly neutralizing antibodiesNico Pfeifer, Hauke Walter, Thomas Lengauer
Journal of Clinical Microbiology|August 9, 2003
Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test resultsKlaus Korn, Heide Reil, Hauke Walter, et al.
AIDS Reviews|November 6, 2002
Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapyBarbara Schmidt, Hauke Walter, Nina Zeitler, et al.
Journal of the International AIDS Society|November 15, 2014
Appearance of NS3 Q80K mutation in HCV genotype 1a mono- or HIV/HCV co-infected patients in a Berlin laboratoryRobert Ehret, Stefan Neifer, Hauke Walter, et al.
Journal of the International AIDS Society|November 15, 2014
Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequencesAlejandro Pironti, Nico Pfeifer, Rolf Kaiser, et al.
Antimicrobial Agents and Chemotherapy|December 26, 2001
Prediction of abacavir resistance from genotypic data: impact of zidovudine and lamivudine resistance in vitro and in vivoHauke Walter, Barbara Schmidt, Marianne Werwein, et al.
Antiviral Research|March 23, 2010
The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitroDaniel Drogan, Pia Rauch, Daniel Hoffmann, et al.
Pageof 4